Skip to main content
OpenTrials

Clinical trial condition

Breast Diseases

Explore clinical trials studying Breast Diseases. Study availability and eligibility vary by location and protocol.

10,420 public trials 2,005 recruiting studies
Refine in advanced search Browse all conditions

Breast Diseases trial results

Active, not recruiting

Study to Determine the Safety, Tolerability, Pharmacokinetics and Recommended Phase 2 Dose (RP2D) of Livmoniplimab (ABBV-151) as a Single Agent and in Combination With Budigalimab (ABBV-181) in Participants With Locally Advanced or Metastatic Solid Tumors

NCT03821935

Conditions
Adenocarcinoma, Advanced Solid Tumors Cancer, Breast Diseases, +28 more
Locations
  • Highlands Oncology Group, PA /ID# 218942 Springdale, Arkansas, United States
  • City of Hope National Medical Center /ID# 265620 Duarte, California, United States
  • City of Hope Orange County Lennar Foundation Cancer Center /ID# 270785 Irvine, California, United States
  • Yale University School of Medicine /ID# 208356 New Haven, Connecticut, United States
View all 64 locations
View Trial Details
Active, not recruiting

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

NCT04140526

Conditions
Adenocarcinoma, Adenoid Cystic Carcinoma, Adnexal Diseases, +94 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • University of California at Davis Davis, California, United States
  • The Oncology Institute of Hope and Innovation Downey, California, United States
  • City of Hope Cancer Center Duarte, California, United States
View all 37 locations
View Trial Details
Active, not recruiting

Tomosynthesis Mammographic Imaging Screening Trial

NCT02616432

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • X-Ray 505 (Under the BCCA Screening Mammography Program of BC) Vancouver, British Columbia, Canada
  • Breast Health Centre at BC Women's Hospital + Health Centre Vancouver, British Columbia, Canada
  • The Ottawa Hospital Ottawa, Ontario, Canada
  • Sunnybrook Health Sciences Centre Toronto, Ontario, Canada
View Trial Details
Active, not recruiting

CFI-402257, a Potent and Selective TTK Inhibitor, in Solid Tumors and With Fulvestrant in Breast Cancer

NCT05251714

Conditions
Advanced Solid Tumor, Breast Cancer, Breast Diseases, +5 more
Locations
  • The Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • START San Antonio San Antonio, Texas, United States
  • START - Mountain Region West Valley City, Utah, United States
  • Virginia Cancer Specialist Fairfax, Virginia, United States
View Trial Details

Related conditions